Literature DB >> 23597432

Tryptophan metabolism and immunogenetics in major depression: a role for interferon-γ gene.

Aye Mu Myint1, Brigitta Bondy, Thomas C Baghai, Daniela Eser, Caroline Nothdurfter, Cornelius Schüle, Peter Zill, Norbert Müller, Rainer Rupprecht, Markus J Schwarz.   

Abstract

The tryptophan metabolism and immune activation play a role in pathophysiology of major depressive disorders. The pro-inflammatory cytokine interferon-γ transcriptionally induces the indoleamine 2,3-dioxygenase enzyme that degrades the tryptophan and thus induces serotonin depletion. The polymorphism of certain cytokine genes was reported to be associated with major depression. We investigated the association between interferon-γ (IFNγ) gene CA repeat polymorphism, the profile of serotonin and tryptophan pathway metabolites and clinical parameters in 125 depressed patients and 93 healthy controls. Compared to controls, serum tryptophan and 5-hydroxyindoleacetic acid (5HIAA) concentrations in the patients were significantly lower and serum kynurenine concentrations were significantly higher at baseline (p<0.0001). The presence of IFNγ CA repeat allele 2 homozygous has significant association with higher kynurenine concentrations in controls (F=4.47, p=0.038) as well as in patients (F=3.79, p=0.045). The existence of interferon-γ CA repeat allele 2 (homo- or heterozygous) showed significant association with increase of tryptophan breakdown over time during the study period (F=6.0, p=0.019). The results indicated the association between IFNγ CA repeat allele 2, tryptophan metabolism and the effect of medication.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23597432     DOI: 10.1016/j.bbi.2013.04.003

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  24 in total

Review 1.  The microbiome: stress, health and disease.

Authors:  Rachel D Moloney; Lieve Desbonnet; Gerard Clarke; Timothy G Dinan; John F Cryan
Journal:  Mamm Genome       Date:  2013-11-27       Impact factor: 2.957

Review 2.  Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies.

Authors:  Gislaine Z Réus; Karen Jansen; Stephanie Titus; André F Carvalho; Vilma Gabbay; João Quevedo
Journal:  J Psychiatr Res       Date:  2015-05-19       Impact factor: 4.791

Review 3.  Inflammatory cytokine-associated depression.

Authors:  Francis E Lotrich
Journal:  Brain Res       Date:  2014-07-05       Impact factor: 3.252

4.  Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies.

Authors:  Danilo Arnone; Smita Saraykar; Haitham Salem; Antonio L Teixeira; Robert Dantzer; Sudhakar Selvaraj
Journal:  Neurosci Biobehav Rev       Date:  2018-06-22       Impact factor: 8.989

Review 5.  Disturbed tryptophan metabolism in cardiovascular disease.

Authors:  H Mangge; I Stelzer; E Z Reininghaus; D Weghuber; T T Postolache; D Fuchs
Journal:  Curr Med Chem       Date:  2014-06       Impact factor: 4.530

6.  Involvement of Host Defense Mechanisms against Toxoplasma gondii Infection in Anhedonic and Despair-Like Behaviors in Mice.

Authors:  Motamed Elsayed Mahmoud; Ragab Fereig; Yoshifumi Nishikawa
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

7.  Kynurenine pathway and white matter microstructure in bipolar disorder.

Authors:  Sara Poletti; Aye Mu Myint; Gregor Schüetze; Irene Bollettini; Elena Mazza; Doris Grillitsch; Clara Locatelli; Markus Schwarz; Cristina Colombo; Francesco Benedetti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-09-12       Impact factor: 5.270

8.  Malaise, melancholia and madness: the evolutionary legacy of an inflammatory bias.

Authors:  Charles L Raison; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2013-04-30       Impact factor: 7.217

9.  Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects.

Authors:  Emil F Coccaro; Royce Lee; Jennifer R Fanning; Dietmar Fuchs; Michel Goiny; Sophie Erhardt; Kyle Christensen; Lena Brundin; Mary Coussons-Read
Journal:  Psychoneuroendocrinology       Date:  2016-05-06       Impact factor: 4.905

10.  Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).

Authors:  Yan Li; Amanda R Eskelund; Hua Zhou; David P Budac; Connie Sánchez; Maria Gulinello
Journal:  Int J Mol Sci       Date:  2015-07-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.